Dual Promoter–Controlled Oncolytic Adenovirus CG5757 Has Strong Tumor Selectivity and Significant Antitumor Efficacy in Preclinical Models
暂无分享,去创建一个
S. Thorne | P. Working | T. Reid | M. Vanroey | G. Colbern | N. Idamakanti | Yuanhao Li | N. Nguyen | De-chao Yu | T. Arroyo | S. Nichols | Orlena Tam